Searched for
VACCINE DIFFERENTIATION
Maternity cover in group health insurance plans: Why outdated limits leave employees paying more out of pocketOne of the biggest advantages of a group policy is the waiver of the maternity waiting period. In individual policies, maternity typically ...- Tata 1mg turns Ebitda positive across core units as diagnostics crosses Rs 600 crore in ARRThe company said its diagnostics business crossed an annualised revenue run rate of more than Rs 600 crore during the year, growing over 40...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Biovet gets CDSCO nod for lumpy skin disease vaccineBiovet has received approval from the CDSCO to market Biolumpvaxin, the world's only marker vaccine for Lumpy Skin Disease in cattle and bu...
- France's Sanofi signs COVID-19 vaccine deal with NovavaxSanofi and Novavax partnered for a COVID-19 vaccine deal. Novavax will receive $1.2 billion in milestones. Sanofi will take an equity stake...
- G20: Goyal calls to end new trade barriers like vax differentiation, Covid passportsPitching for free flow of health services to make them accessible and more affordable at the G20 Trade and Investment Ministerial Meeting i...
- Covid passport, vaccine discrimination new trade barriers: India to WTO"WTO response should not only try to address the existing trade barriers like export restrictions, but also address new and emerging ones, ...
- Zydus vaccine likely to cost Rs 300 a doseHealth secretary Rajesh Bhushan on Thursday had spoken about the pricing. "We are in conversation with the manufacturer. Since it is a thre...
- Government lab releases first batch of Zydus Cadila's covid vaccine ZyCoV-DNeedle-free ZyCoV-D, manufactured by Ahmedabad-based Zydus Cadila, is the first Covid-19 vaccine approved for the 12 to 18 years age group ...
- Days before PM's announcement for free COVID jabs to 18+, SC asked for review of vaccination policyThe development assumes significance as the central government was posed a slew of searching queries by a bench headed by Justice D Y Chand...
- SC questions differential vaccine pricing, raises urban-rural divideThe Centre, which said it expects to inoculate all Indians by the end of the year, has to respond to the questions raised by the court in t...
- Kerala HC seeks timeframe from Centre within which State is likely to get COVID-19 vaccinesThe Kerala High Court on Friday sought a timeframe from the Centre within which the southern state is likely to get the COVID-19 vaccines. ...
- Supreme Court wants Centre to ensure COVID-19 vaccines for all at low pricesThe top court asked the Centre for details about the grants made to Serum Institute of India (SII) and Bharat Biotech. It urged the Centre ...
- Covishield price for states slashed from Rs 400 to Rs 300 per dose: Adar PoonawallaThe SII, which is India's largest vaccine manufacturer, had earlier priced Covishield at Rs 400 per dose for the state governments and Rs 6...
- Congress highlights shortage of COVID-19 vaccines in country, asks Centre to focus on issueIn another tweet, Rahul Gandhi asked the Centre to focus on vaccines, oxygen and other health services amid the COVID-19 pandemic, instead ...
- 'Atrocious': Jairam Ramesh slams Centre over differential Covishield pricingSenior Congress leader Jairam Ramesh on Wednesday criticised the Union government over differential pricing of Covishield vaccine, saying t...
- Pfizer promises tiered pricing for its Covid-19 vaccine“We will have tiered pricing for middle-income countries (India is considered a middle-income country) and we will give it for free in Afri...
- Pfizer set to start coronavirus immunization pilot program in four American statesThe four states – Rhode Island, Texas, New Mexico, and Tennessee – were selected for the program because of their differences in overall si...
- University of Houston partners Indian-American co-founded company for COVID-19 vaccineAuraVax, however, has the option to exclusively license a new intranasal vaccine technology developed by its Indian-American co-founder, Na...
- Innovation key to ride vaccine boom: Dr Rajesh Jain, Panacea BiotecIt is a capital-intensive business where companies require upfront payments to fund R&D activities, says Dr Rajesh Jain, joint managing dir...
Load More
